Peter Winkley
Director of Finance/CFO bei ALGOMA CENTRAL CORPORATION
Vermögen: 190 235 $ am 31.03.2024
Profil
Peter W Winkley is currently the Chairman at The Canadian Shipowners Mutual Assurance Association since 2012 and the Chief Financial Officer & Executive Vice President at Algoma Central Corp.
since 2010.
Previously, he served as the Chairman at SQI Diagnostics, Inc. from 2014 to 2015.
He also held positions as a Director at NorthStandard Ltd., Vice President-Finance at Nordion (Canada), Inc., and Chief Financial Officer & Vice President-Finance at Therapure Biopharma, Inc. from 2008 to 2009.
Mr. Winkley obtained his undergraduate degree from the University of Toronto in 1982.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.03.2024 | 17 517 ( 0,05% ) | 190 235 $ | 31.03.2024 |
Aktive Positionen von Peter Winkley
| Unternehmen | Position | Beginn |
|---|---|---|
| ALGOMA CENTRAL CORPORATION | Director of Finance/CFO | 21.09.2011 |
The Canadian Shipowners Mutual Assurance Association
 The Canadian Shipowners Mutual Assurance Association Insurance Brokers/ServicesFinance The Canadian Shipowners Mutual Assurance Association insure candadian ships against war risk. It offers insurance by the government of canada and by the standard steamship owners' mutual war risk association limited. The company was founded in 1953 and is headquartered in Toronto, Canada. | Chairman | 01.02.2012 |
Ehemalige bekannte Positionen von Peter Winkley
| Unternehmen | Position | Ende |
|---|---|---|
| SQI DIAGNOSTICS INC. | Chairman | 07.04.2015 |
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Director of Finance/CFO | 01.12.2009 |
NorthStandard Ltd.
 NorthStandard Ltd. Property/Casualty InsuranceFinance The North of England Protecting & Indemnity Association Ltd. provides marine insurance services. It offers protection and indemnity insurance, freight demurrage, defense, and war risk coverage services to 3100 merchant ships worldwide. The company was founded in 1886 and is headquartered in Newcastle-upon-Tyne, UK. | Director/Board Member | - |
| NORDION INC | Director of Finance/CFO | - |
Ausbildung von Peter Winkley
| University of Toronto | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALGOMA CENTRAL CORPORATION | Transportation |
| SQI DIAGNOSTICS INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Health Technology |
NorthStandard Ltd.
NorthStandard Ltd. Property/Casualty InsuranceFinance The North of England Protecting & Indemnity Association Ltd. provides marine insurance services. It offers protection and indemnity insurance, freight demurrage, defense, and war risk coverage services to 3100 merchant ships worldwide. The company was founded in 1886 and is headquartered in Newcastle-upon-Tyne, UK. | Finance |
The Canadian Shipowners Mutual Assurance Association
The Canadian Shipowners Mutual Assurance Association Insurance Brokers/ServicesFinance The Canadian Shipowners Mutual Assurance Association insure candadian ships against war risk. It offers insurance by the government of canada and by the standard steamship owners' mutual war risk association limited. The company was founded in 1953 and is headquartered in Toronto, Canada. | Finance |
